Skip to Content
Merck
CN
  • NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds.

NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds.

Bioorganic & medicinal chemistry (2008-08-20)
Joerg Konter, Ute Möllmann, Jochen Lehmann
ABSTRACT

Novel hybrid compounds combining the antifungal drug ketoconazole with a diazen-1-ium-1,2-diolate or an organic nitrate moiety and the corresponding NO-donors without ketoconazole were synthesized and their activities against a broad variety of fungal strains were tested. Hybridization modifies the spectrum of antimicrobial activities and generally, the ketoconazole-NO-donor hybrids are more potent than ketoconazole. The NO-donors alone show insufficient effectiveness.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ketoconazole, 99.0-101.0% (EP, titration)